NEW YORK (GenomeWeb News) — The Specialized Clinical Center of Research in Houston will use Bioserve’s Global Repository to study genetic links to thoracic aortic disease, Bioserve said today.
Bioserve said it will provide the SCCOR with access to “certain unique sample sets” from the company’s repository, which includes 600,000 DNA, tissue, and serum samples along with clinical and demographic data.
The SCCOR program is a collaborative effort of the University of Texas Health Science Center Houston, Baylor College of Medicine, and the University of Texas Medical Branch.
The company said the SCCOR will use the samples to look for genes that can predict the development and progression of thoracic aortic diseases.
The SCCOR study is funded by a five-year grant from the National Heart, Lung and Blood Institute.
Financial terms of the agreement were not released.